# Brostallicin Clinical Trial for Myxoid Liposarcoma

> **NCT00633165** · PHASE2 · UNKNOWN · sponsor: **Systems Medicine LLC** · enrollment: 24 (estimated)

## Conditions studied

- Myxoid Liposarcoma

## Interventions

- **DRUG:** Brostallicin

## Key facts

- **NCT ID:** NCT00633165
- **Lead sponsor:** Systems Medicine LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-08
- **Primary completion:** 2008-10
- **Final completion:** 2010-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2010-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633165, "Brostallicin Clinical Trial for Myxoid Liposarcoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00633165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*